Packages (Simulation)
Reagent Preparation
Image (I)
Certificate
CLIA Kit for Pleiotrophin (PTN)
HARP; HBGF8; HBNF; NEGF1; Heparin Binding Growth Factor 8; Neurite Growth-Promoting Factor 1; Heparin Affin Regulatory Peptide; Heparin Binding Growth Associated Molecule
- Product No.SCB309Mu
- Organism SpeciesMus musculus (Mouse) Same name, Different species.
- Sample TypeSerum, plasma and other biological fluids
- Test MethodDouble-antibody Sandwich
- Assay Length2h, 40min
- Detection Range2.74-2,000pg/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 1.17pg/mL.
- DownloadInstruction Manual
- UOM 48T96T 96T*5 96T*10 96T*100
- FOB
US$ 605
For more details, please contact local distributors! US$ 864 US$ 3888 US$ 7344 US$ 60480
Specificity
This assay has high sensitivity and excellent specificity for detection of Pleiotrophin (PTN).
No significant cross-reactivity or interference between Pleiotrophin (PTN) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Pleiotrophin (PTN) and the recovery rates were calculated by comparing the measured value to the expected amount of Pleiotrophin (PTN) in samples.
Matrix | Recovery range (%) | Average(%) |
serum(n=5) | 79-94 | 87 |
EDTA plasma(n=5) | 83-98 | 86 |
heparin plasma(n=5) | 98-105 | 102 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Pleiotrophin (PTN) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Pleiotrophin (PTN) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Pleiotrophin (PTN) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Sample | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 84-102% | 90-97% | 81-91% | 84-91% |
EDTA plasma(n=5) | 79-101% | 94-101% | 93-101% | 79-92% |
heparin plasma(n=5) | 78-103% | 82-102% | 80-104% | 79-95% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
Reagents | Quantity | Reagents | Quantity |
Pre-coated, ready to use 96-well strip plate | 1 | Plate sealer for 96 wells | 4 |
Standard | 2 | Standard Diluent | 1×20mL |
Detection Reagent A | 1×120µL | Assay Diluent A | 1×12mL |
Detection Reagent B | 1×120µL | Assay Diluent B | 1×12mL |
Substrate A | 1×10mL | Substrate B | 1×2mL |
Wash Buffer (30 × concentrate) | 1×20mL | Instruction manual | 1 |
Assay procedure summary
1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 100µL Substrate Solution. Incubate 10 minutes at 37°C;
8. Read RLU value immediately.
GIVEAWAYS
INCREMENT SERVICES
- Single-component Reagents of Assay Kit
- Lysis Buffer Specific for ELISA / CLIA
- Quality Control of Kit
- CLIA Kit Customized Service
- Disease Model Customized Service
- Serums Customized Service
- TGFB1 Activation Reagent
- Real Time PCR Experimental Service
- Streptavidin
- Fast blue Protein Stain solution
- Single-component Reagents of FLIA Kit
- Streptavidin-Agarose Beads
Magazine | Citations |
Oncogene | Suppression of lung adenocarcinoma through menin and polycomb gene-mediated repression of growth factor pleiotrophinMenin suppresses lung cancer through PTN Nature: 2009273 |
PLOS ONE | The Effects of Pleiotrophin in Proliferative Diabetic Retinopathy Pubmed:25617851 |
Infect Immun. | Depletion of Phagocytic Cells during Nonlethal Plasmodium yoelii Infection Causes Severe Malaria Characterized by Acute Renal Failure in Mice. Pubmed:26755155 |
In Vivo | Evaluation of Serum Biomarkers (FGF-2, HGF, MIF and PTN) in Patients With Testicular Germ Cell Cancer Pubmed: 31662522 |
Catalog No. | Related products for research use of Mus musculus (Mouse) Organism species | Applications (RESEARCH USE ONLY!) |
RPB309Mu01 | Recombinant Pleiotrophin (PTN) | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB309Mu02 | Recombinant Pleiotrophin (PTN) | Positive Control; Immunogen; SDS-PAGE; WB. |
PAB309Mu02 | Polyclonal Antibody to Pleiotrophin (PTN) | WB; IHC; ICC; IP. |
PAB309Mu01 | Polyclonal Antibody to Pleiotrophin (PTN) | WB; IHC; ICC; IP. |
LAB309Mu71 | Biotin-Linked Polyclonal Antibody to Pleiotrophin (PTN) | WB; IHC; ICC. |
SEB309Mu | ELISA Kit for Pleiotrophin (PTN) | Enzyme-linked immunosorbent assay for Antigen Detection. |
SCB309Mu | CLIA Kit for Pleiotrophin (PTN) | Chemiluminescent immunoassay for Antigen Detection. |
LMB309Mu | Multiplex Assay Kit for Pleiotrophin (PTN) ,etc. by FLIA (Flow Luminescence Immunoassay) | FLIA Kit for Antigen Detection. |